RAPS Convergence (in-person) attracts 2,000 professionals in the areas of medical devices, IVDs, biopharmaceuticals and biotech.

 

RAPS Convergence 2021 by the numbers

12 – 15 September 2021 (virtual conference)

 

ATTENDEES
1,516

CONTINENTS
6

COUNTRIES
37
 

 

Region
North
America
83%
Oceania 0.5%
Asia 2%
Europe 9%
Africa 0.1%
Latin America
& Caribbean 
1%
Not specified 4%
Industry
Academic Institution 2%
Communications 0.2%
Consulting 12%
CRO 5%
Government 8%
Hospital/
Medical Practice
2%
Industry
Organization
60%
Laboratory 2%
Law Firm 0.2%
Media 1%
Notified Body 1%
Not-for-profit/
Association
1%
Publishing 0.1%
Self-employed 1%
Software 3%
Talent Acquisition 0.2%
Training/Education 0.3%
Translations 0.0%
Other 1%
Job Function
CEO/President/
Executive Director
6%
Vice President/
Director
26%
Manager/Project Manager 25%
Specialist/Associate/
Coordinator
17.3%
Consultant 6%
Professor/
Academic Faculty
0.5%
Analyst 2%
Compliance Officer/
Consumer Safety Officer
1.1%
Physician/Pharmacist/
Health Professional
0.5%
Regulatory Counsel 2%
Regulatory Information Specialist 9%
Student 0.5%
Retired 0.1%
Other 4%
Sectors of Interest
APIs 14%
Biologics 43%
Biotechnology 39%
Combination
Products
48%
Diagnostics 27%
Nutritional/
natural Health
9%
Medical Devices 71%
OTC 14%
Pharmaceuticals 51%
Other 6%

 

54% are involved in various stages of the purchasing process

 

Purchasing Role
Final decision maker 17%
Recommend products
and/or specify vendors
27%
Influence purchase decisions 28%
Research new products 19%
No role 46%
Purchasing Authority
$5,000,000+ 2%
$1,000,001 - $5,000,000 2%
$500,001 - $1,000,000 1%
$100,001 - $500,000 8%
$25,001 - $100,000 5%
Less than $25,000 82%
Purchasing Intentions
(next 12 months)
Biotechnology 15%
Clinical research organization (CRO) 13%
Communications 7%
Conformity assessments 11%
Consulting 28%
Education and training 37%
Legal 9%
Marketing 5%
Medical devices 31%
Notified Body 22%
Pharmaceutical 14%
Recruitment and staffing 11%
Regulatory information management 31%
Regulatory intelligence 41%
Software 17%
Translation 8%
Other 10%